These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11978375)

  • 1. Coagulation, angiogenesis, and venous thromboembolism in cancer.
    Agorogiannis EI; Agorogiannis GI
    Lancet; 2002 Apr; 359(9315):1440. PubMed ID: 11978375
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiostatin enhances B7.1-mediated cancer immunotherapy independently of effects on vascular endothelial growth factor expression.
    Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
    Cancer Gene Ther; 2001 Oct; 8(10):719-27. PubMed ID: 11687895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and antiangiogenic therapy.
    Sledge GW; Miller KD
    Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
    [No Abstract]   [Full Text] [Related]  

  • 4. The detection and comparison of angiogenesis-associated factors in pyogenic granuloma by immunohistochemistry.
    Yuan K; Jin YT; Lin MT
    J Periodontol; 2000 May; 71(5):701-9. PubMed ID: 10872949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor angiogenesis].
    Ono M; Kuwano M
    Seikagaku; 1998 Sep; 70(9):1159-70. PubMed ID: 9796411
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship of blood clotting and tumor angiogenesis.
    Rickles FR
    Haemostasis; 2001; 31 Suppl 1():16-20. PubMed ID: 11990466
    [No Abstract]   [Full Text] [Related]  

  • 8. [Opening to the age of regenerative medicine--the mechanism of angiogenesis].
    Murota S
    Kokubyo Gakkai Zasshi; 2002 Jun; 69(2):81-8. PubMed ID: 12136664
    [No Abstract]   [Full Text] [Related]  

  • 9. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
    Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
    FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment.
    Fidler IJ
    J Natl Cancer Inst; 2001 Jul; 93(14):1040-1. PubMed ID: 11459857
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.
    Phillips P
    JAMA; 1998 Jun; 279(24):1936-7. PubMed ID: 9643843
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vascular growth and non-small cell lung cancer].
    Fan X; Guo X; Han B
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):499-502. PubMed ID: 11718044
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiangiogenic therapy].
    Toi M
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incipient angiogenesis.
    Folkman J
    J Natl Cancer Inst; 2000 Jan; 92(2):94-5. PubMed ID: 10639502
    [No Abstract]   [Full Text] [Related]  

  • 15. Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.
    Hayes AJ; Li LY; Lippman ME
    BMJ; 1999 Mar; 318(7187):853-6. PubMed ID: 10092266
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.
    Yamahata H; Takeshima H; Kuratsu J; Sarker KP; Tanioka K; Wakimaru N; Nakata M; Kitajima I; Maruyama I
    Int J Oncol; 2002 May; 20(5):921-8. PubMed ID: 11956584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic relevance of angiogenic, proliferative, and apoptotic factors in lung carcinomas. A case review.
    Volm M; Koomägi R
    Methods Mol Med; 2003; 74():269-82. PubMed ID: 12415702
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor (VEGF) likely contributes to oligodendroglioma angiogenesis.
    Christov C; Gherardi RK
    Acta Neuropathol; 1999 Apr; 97(4):429-32. PubMed ID: 10208285
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk factors for diabetic complications: Angiogenesis factor].
    Katsura Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():73-8. PubMed ID: 12430210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.